Delivery Order SPE2DB22D1002-SPE2DB25FLHN4
- Not listed
- The Defense Logistics Agency awarded a $17,790.58 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes on August 15, 2025, with a completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,039.25 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 Syringe 0.5ML, a pneumococcal vaccine product. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by August 25, 2025, with the place of performance located in Conshohocken, Pennsylvania, the vendor's corporate headquarters. This delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $26,021.15 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccines in 0.5 mL syringe format on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $17,538.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine syringes (0.5mL) on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside competitive award is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $23,429.21 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-competitive, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine procurement under the company's larger relationship with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,281.88 to supply PREVNAR 20 syringes (0.5ML) under a firm fixed price contract. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 11, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $14,384.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ML syringes. This non-set-aside contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $6,337.95 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5 mL syringe format. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $4,901.31 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's Conshohocken, Pennsylvania location. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $6,926.00 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes. Issued on July 29, 2025, with an ultimate completion date of July 30, 2025, this firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHN4Delivery Order
The Defense Logistics Agency awarded a $16,250.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ML syringe format on September 11, 2025, with completion targeted for September 12, 2025. This competitive award carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. The delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's extensive federal contract portfolio with the Defense Logistics Agency's Medical Supply Chain. The company's demonstrated capability to compete and perform across multiple therapeutic domains—including vaccines, specialty medications, brand-name and generic drugs, and medical supplies—positions it as a primary supplier for Department of Defense healthcare systems, the Defense Health Agency, and other federal healthcare entities. PREVNAR 20, a pneumococcal vaccine, addresses critical immunization requirements for military personnel and beneficiaries within the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 9/11/25 |